Jesse Medical Technologies supports the clinicians by providing an easy to use, and objective measure of Parkinson’s disease symptoms. We understand that Parkinson’s disease symptoms are complex, and we provide the tools for early stage diagnostics.
We provide specialised Parkinson diagnosis tests utilising novel technology that assesses bradykinesia, rigidity and tremor, and the motor impact of cognitive loading.
While typical disease markers and the symptom of micrographia may remain unnoticed or misdiagnosed in the early stages of disease progression, our dynamic test, using patented technology, is able to overcome these limitations with clinical prospective cohort studies demonstrating accurate Parkinson’s disease screening.
We are at the forefront of fighting Parkinson’s disease globally as the early diagnosis significantly improves disease prognosis. We not only provide an early stage detection, we also provide means for regular monitoring of the disease and a very good estimate of the UPDRS-III for the patient.
The screening service takes a mere 5 minutes to complete whilst providing an extensive report directly to the clinic. This report includes information that would otherwise require over an hour of testing via expert clinicians. It also creates the clinical record of each patient.